Northern Trust’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$83.8K Sell
188,869
-229,745
-55% -$102K ﹤0.01% 4149
2025
Q1
$237K Sell
418,614
-30,403
-7% -$17.2K ﹤0.01% 3879
2024
Q4
$947K Sell
449,017
-3,019
-0.7% -$6.37K ﹤0.01% 3419
2024
Q3
$1.22M Buy
452,036
+3,414
+0.8% +$9.18K ﹤0.01% 3273
2024
Q2
$1.28M Sell
448,622
-7,475
-2% -$21.3K ﹤0.01% 3139
2024
Q1
$1.93M Sell
456,097
-11,551
-2% -$49K ﹤0.01% 2982
2023
Q4
$2.5M Buy
467,648
+940
+0.2% +$5.03K ﹤0.01% 2875
2023
Q3
$2.01M Buy
466,708
+5,306
+1% +$22.8K ﹤0.01% 2936
2023
Q2
$2.53M Buy
461,402
+269,103
+140% +$1.48M ﹤0.01% 2874
2023
Q1
$808K Buy
192,299
+1,383
+0.7% +$5.81K ﹤0.01% 3288
2022
Q4
$529K Sell
190,916
-629
-0.3% -$1.74K ﹤0.01% 3485
2022
Q3
$490K Sell
191,545
-422,570
-69% -$1.08M ﹤0.01% 3516
2022
Q2
$2.21M Buy
614,115
+157,631
+35% +$568K ﹤0.01% 3000
2022
Q1
$2.83M Sell
456,484
-23,758
-5% -$147K ﹤0.01% 2917
2021
Q4
$3.39M Sell
480,242
-9,650
-2% -$68K ﹤0.01% 2940
2021
Q3
$3.42M Sell
489,892
-8,256
-2% -$57.6K ﹤0.01% 2981
2021
Q2
$4.15M Buy
498,148
+14,671
+3% +$122K ﹤0.01% 2964
2021
Q1
$2.64M Sell
483,477
-133,506
-22% -$729K ﹤0.01% 3104
2020
Q4
$2.65M Sell
616,983
-25,767
-4% -$111K ﹤0.01% 3051
2020
Q3
$1.94M Buy
642,750
+259,961
+68% +$783K ﹤0.01% 3082
2020
Q2
$1.19M Buy
382,789
+223,997
+141% +$694K ﹤0.01% 3297
2020
Q1
$350K Buy
158,792
+1,247
+0.8% +$2.75K ﹤0.01% 3538
2019
Q4
$480K Sell
157,545
-900
-0.6% -$2.74K ﹤0.01% 3568
2019
Q3
$487K Sell
158,445
-269,899
-63% -$830K ﹤0.01% 3544
2019
Q2
$857K Sell
428,344
-17,386
-4% -$34.8K ﹤0.01% 3404
2019
Q1
$1.92M Buy
445,730
+2,506
+0.6% +$10.8K ﹤0.01% 3109
2018
Q4
$1.41M Buy
443,224
+1,034
+0.2% +$3.29K ﹤0.01% 3227
2018
Q3
$2.32M Buy
442,190
+51,036
+13% +$268K ﹤0.01% 3139
2018
Q2
$2.09M Buy
391,154
+302,184
+340% +$1.62M ﹤0.01% 3185
2018
Q1
$445K Sell
88,970
-1,651
-2% -$8.26K ﹤0.01% 3603
2017
Q4
$299K Buy
90,621
+5,216
+6% +$17.2K ﹤0.01% 3684
2017
Q3
$320K Sell
85,405
-800
-0.9% -$3K ﹤0.01% 3658
2017
Q2
$220K Buy
86,205
+4,260
+5% +$10.9K ﹤0.01% 3767
2017
Q1
$213K Buy
81,945
+3,209
+4% +$8.34K ﹤0.01% 3774
2016
Q4
$240K Buy
78,736
+2,884
+4% +$8.79K ﹤0.01% 3711
2016
Q3
$206K Buy
75,852
+495
+0.7% +$1.34K ﹤0.01% 3726
2016
Q2
$215K Sell
75,357
-260,892
-78% -$744K ﹤0.01% 3702
2016
Q1
$1.02M Buy
336,249
+2,225
+0.7% +$6.72K ﹤0.01% 3245
2015
Q4
$1.16M Sell
334,024
-1,094
-0.3% -$3.8K ﹤0.01% 3271
2015
Q3
$1.27M Buy
335,118
+240,945
+256% +$911K ﹤0.01% 3244
2015
Q2
$537K Buy
94,173
+25,846
+38% +$147K ﹤0.01% 3541
2015
Q1
$398K Sell
68,327
-8,573
-11% -$49.9K ﹤0.01% 3674
2014
Q4
$436K Sell
76,900
-104
-0.1% -$590 ﹤0.01% 3588
2014
Q3
$315K Sell
77,004
-209,332
-73% -$856K ﹤0.01% 3693
2014
Q2
$1.3M Sell
286,336
-48,148
-14% -$219K ﹤0.01% 3294
2014
Q1
$1.59M Sell
334,484
-22,836
-6% -$108K ﹤0.01% 3239
2013
Q4
$1.68M Sell
357,320
-115,903
-24% -$545K ﹤0.01% 3233
2013
Q3
$1.89M Buy
473,223
+872
+0.2% +$3.48K ﹤0.01% 3122
2013
Q2
$1.68M Buy
+472,351
New +$1.68M ﹤0.01% 3077